Chronic myeloid leukemia
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 17 (5) , 1159-1173
- https://doi.org/10.1016/s0889-8588(03)00088-1
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003
- Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013Leukemia & Lymphoma, 2003
- Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous LeukemiaNew England Journal of Medicine, 2002
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new scoreBritish Journal of Haematology, 1997
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990
- Acute leukaemia in bcr/abl transgenic miceNature, 1990
- Induction of Chronic Myelogenous Leukemia in Mice by the P210
bcr/abl
Gene of the Philadelphia ChromosomeScience, 1990
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical TwinNew England Journal of Medicine, 1979